Rehabilitation Equipment Market Size Hits USD 18.42 Billion in 2025, Set to Cross USD 37.34 Billion by 2034
Ottawa, July 25, 2025 (GLOBE NEWSWIRE) -- The global rehabilitation equipment market size was valued at USD 17 billion in 2024 and is predicted to hit around USD 37.34 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research.
The growth of the market is driven the growing demand from consumers for specialized equipment, and benefits offered by the equipment's with improved quality of life and faster recovery rate which fuels the growth of the market.Report Highlights of Rehabilitation Equipment Market:
North America dominated the global rehabilitation equipment market share by 43% in 2024.
Asia-Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
By type, the therapy equipment segment held a dominant presence in the market in 2024.
By type, the daily living aids segment is expected to grow at the fastest rate in the market during the forecast period.
By application, the occupational rehabilitation & training segment led the global market in 2024.
By application, the physical rehabilitation & training segment is anticipated to grow with the highest CAGR in the market during the studied years.
By end-use, the hospitals & clinics segment held the largest share of the market in 2024.
By end-use, the rehabilitation centers segment is predicted to witness significant growth in the market over the forecast period.
Market Overview & Potential
What are Rehabilitation Equipment?
Rehabilitation equipment includes various tools and devices that assist individuals in recovery from injuries, surgeries, or illnesses, helping them restore lost abilities. These tools aim to enhance mobility, strength, coordination, and independence. Main categories include Mobility Aids such as wheelchairs, walkers, canes, and crutches; Prosthetics and orthotics; Physiotherapy Equipment like treadmills, stationary bikes, resistance bands, weights, balance boards, foam rollers, and range of motion devices; Electrotherapy devices, traction devices, ultrasound machines; and Occupational Therapy Equipment such as hand exercisers and therapy.What is the Growth Potential Responsible for the Growth of the Rehabilitation Equipment Market?
Rehabilitation equipment drivers in physical therapy and disability refer to tools, devices, and technologies designed to help individuals restore or preserve their physical abilities and independence. This category includes a variety of items such as wheelchairs, prosthetics, orthotics, assistive devices, and therapy tools. These tools are essential for rehabilitation programs focused on enhancing mobility, strength, balance, and overall function.
What Are the Growing Trends Associated with the Rehabilitation Equipment Market?
An Aging Population and Chronic Diseases
The growth is driven by the increasing number of patients with an ageing population, with increasing demand for rehabilitation services for management of treatment and healthcare.
Technological Advancements
The growing advancement in technology, like integration of AI, smart devices, virtual and augmented reality, remote monitoring, and robotics, are some of the major growth factors.
Increased Demand for Home Healthcare
Increasing focus on patient empowerment and personalised care, and demand for portable and easy-to-use equipment further fuels the growth of the market.
Supportive Government Policies and Reimbursement
Favorable government policies and support for the development and adoption of he technologies further boost the growth of the market.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
What Is the Growing Challenge in the Rehabilitation Equipment Market?
The global rehabilitation equipment market is growing rapidly, driven by an aging population, increasing rates of chronic diseases, and technological progress. Nevertheless, issues remain in providing access, affordability, and effective use of this equipment. Rebuilding strength, flexibility, and coordination following injury or illness often demands specialized equipment and can be physically challenging. Additionally, rehabilitation can be emotionally difficult, as patients may experience anxiety, depression, and frustration, all of which can affect their participation in therapy.
Regional Analysis:
How Did North America Dominate the Rehabilitation Equipment Market in 2024?
North America dominated the global rehabilitation equipment market share by 43% in 2024. The growth of the market in the region is driven by the growing aging population, which leads to higher prevalence of chronic diseases, advanced healthcare infrastructure, which requires rehabilitation services and equipment, which fuels the growth of the market in the region. The other key factors that fuel the growth are the technological advancements like integration of AI, IoT, and robotics for automation and for enhancing the treatment and patient outcomes, which promote the growth of the market in the region. Key players like Invacre, Medline Industries, Dynatronics, ReWalk Robotics, and DJO Global also play a crucial role in the growth and expansion of the market in the region.
According to Volza's Global Export data, the world shipped out 5,948 Rehabilitation Aid shipments from October 2023 to September 2024 (TTM). These exports were handled by 56 world exporters to 104 buyers, showing a growth rate of 28% over the previous 12 months.
Globally, India, China, and the United Arab Emirates are the top three exporters of Rehabilitation. India is the global leader in Rehabilitation exports with 12,028 shipments, followed closely by China with 242 shipments, and the United Arab Emirates in third place with 99 shipments.
Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership
What Made Asia Pacific Significantly Grow in the Rehabilitation Equipment Market In 2024?
Asia-Pacific is anticipated to grow at the fastest rate in the market during the forecast period. The growth of the market is driven by the growing and increasing prevalence of disabilities and rising awareness of rehabilitation benefits, which increases the demand for the market, along with the expanding healthcare infrastructure in the region, which supports the growth of the market.
Other key factors that support growth are the growing geriatric population, expanding healthcare infrastructure, increasing government initiatives for promoting healthcare facilities, and affordability, which promotes the growth of the market in the region. The key players in the region also support the expansion and growth of the market through advancements and the integration of modern technologies.
According to Volza's India Export data, India shipped out 6,764 Rehabilitation shipments from October 2023 to September 2024 (TTM). These exports were handled by 20 Indian exporters to 108 buyers, showing a growth rate of 28% over the previous 12 months.
Globally, India, China, and the United Kingdom are the top three exporters of Rehabilitation. India is the global leader in Rehabilitation exports with 16,456 shipments, followed closely by China with 5,850 shipments, and the United Kingdom in third place with 2,347 shipments.
Segmental Insights
By Type
How Did the Therapy Equipment Segment Dominate The Rehabilitation Equipment Market In 2024?
The therapy equipment segment held a dominant presence in the market in 2024. The market is experiencing growth, fueled by innovations like robotic-assisted devices, virtual reality-based therapy, and smart wearable systems. These tools enhance patient engagement, personalization, and treatment effectiveness, especially for neurological, post-surgical, and chronic pain recovery. Their ability to deliver precise, monitored exercise regimes and promote faster functional restoration is driving demand across hospitals, physiotherapy centers, and home-care settings. This surge supports therapy equipment's supports the growth and expansion of the market.
The daily living aids segment is expected to grow at the fastest rate in the market during the forecast period. The market is experiencing strong attention due to addressing the needs of individuals with impaired mobility or chronic conditions. These tools, such as adaptive utensils, grab bars, walkers, and dressing aids, enhance independence, safety, and daily functioning. Their ergonomic designs and ease of use reduce caregiver burden and support aging-in-place. Widely used in home care, assisted living, and outpatient rehab, the growing demand for these aids reflects an increasing focus on quality of life and long-term wellness.
Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes schedule a call today: https://www.towardshealthcare.com/schedule-meeting
By Application
Which Application Segment Dominates The Rehabilitation Equipment Market In 2024?
The occupational rehabilitation & training segment led the global market in 2024. The growth of the market is expanding rapidly, driven by the need to support individuals recovering from injuries, disabilities, or neurological events in regaining functional abilities for everyday work and personal tasks. This category includes simulation-based training tools, task-specific therapy stations, ergonomic workstations, and adaptive devices designed to rebuild fine motor skills, coordination, and cognitive-motor function. Demand is particularly high among physical and occupational therapy clinics, vocational centers, and home-based rehab settings, fostering innovation and market growth.
The physical rehabilitation & training segment is anticipated to grow with the highest CAGR in the market during the studied years. The growth of the market is driven by the increasing demand for recovery support after surgeries, neurological events, and musculoskeletal injuries. This category covers tools such as resistance bands, therapeutic exercise machines, gait trainers, functional electrical stimulation systems, and balance boards, all designed to rebuild strength, flexibility, mobility, and coordination. Widely adopted in hospitals, physiotherapy centers, sports rehab clinics, and home-based care, these solutions enable faster and more effective patient recovery, fueling robust growth and innovation in the market.
By End-Use
How Did Hospitals and Clinics Segment Dominate the Rehabilitation Equipment Market in 2024?
The hospitals & clinics segment held the largest share of the market in 2024. Healthcare facilities rely on a wide range of devices, from therapeutic exercise machines and gait trainers to robotic-assisted systems and electrical stimulation units, to support patient recovery and physical rehabilitation. Hospitals and clinics require high-quality, durable, and clinically validated equipment to deliver effective treatment across orthopedics, neurology, and post-surgical care. Their heavy utilization and preference for advanced technology drive substantial demand, fueling innovation and expansion in the rehabilitation equipment space.
The rehabilitation centers segment is predicted to witness significant growth in the market over the forecast period. These dedicated facilities specialize in comprehensive recovery programs and invest heavily in a diverse range of therapeutic technologies from robotic-assisted devices and gait trainers to virtual-reality systems and functional electrical stimulation units. Their focus on long-term, multidisciplinary care for patients recovering from strokes, spinal cord injuries, and mobility impairments drives demand for advanced, customizable, and patient-centric equipment. This strong utilization supports steady market growth and ongoing product innovation.
Recent Developments
In July 2025, Jin Medical International announced the launch of a production plan in Chuzhou, which will help in accelerating the global delivery of rehabilitation medical equipment, with expert rehabilitation technology and an expanding ecosystem.
Browse More Insights of Towards Healthcare:
The veterinary rehabilitation services market is worth USD 1 billion in 2024 and is projected to reach USD 3.01 billion by 2034, growing at a rate of 11.74% per year.
The stroke rehabilitation market stands at USD 285 million in 2024 and is likely to reach USD 817.06 million by 2034, expanding annually at 11.24%.
The medical rehabilitation services market is valued at USD 270.58 billion in 2024 and is expected to grow to USD 492.4 billion by 2034, at a yearly growth rate of 6.17%.
The behavioral rehabilitation market is projected to grow from USD 171.88 billion in 2025 to USD 235.89 billion by 2034, with a growth rate of 3.58% per year.
The rehabilitation robots market is estimated at USD 430 million in 2024 and is projected to rise to USD 1.77 billion by 2034, growing rapidly at 15.24% annually.
The automated blood processing equipment market is worth USD 2.12 billion in 2024 and is expected to grow to USD 4.41 billion by 2034, with an annual growth rate of 7.65%.
The medical equipment maintenance market is valued at USD 46.16 billion in 2024 and is projected to reach USD 121.94 billion by 2034, expanding at a rate of 10.04% per year.
The dental equipment market is estimated at USD 11.95 billion in 2024 and will likely grow to USD 22.1 billion by 2034, with a growth rate of 6.34% annually.
The personal protective equipment (PPE) market was valued at USD 79.57 billion in 2023 and is projected to reach USD 171.66 billion by 2034, growing at 7.24% per year.
The surgical equipment market was estimated at USD 16.91 billion in 2023 and is expected to grow to USD 45.61 billion by 2034, with an annual growth rate of 9.44%.
Top Players in Rehabilitation Equipment Market:
Activatek, Inc.
Baxter International
Dynatronics
Ekso Bionics
Ergoline GmbH
Hocoma AG
Invacare Corporation
Life Care Systems
Medline Industries
MR Medica
Prism UK Medical Ltd.
RehabGroup, Inc.
Stryker Corporation
Segments Covered in The Report
By Type
Therapy Equipment
Daily Living Aids
Medical Beds & Related Products
Reading, Writing, and Computing Aids
Bathroom & Toilet Assist Devices
Others
Mobility Equipment
Wheelchairs & Scooters
Powered Wheelchairs
Mobility Scooters
Manual Wheelchairs
Walking Assist Devices
Canes
Crutches
Walkers
Body Support Devices
Patient Lifts
Stings
Others
Exercise Equipment
Lower-Body Exercise Equipment
Upper-Body Exercise Equipment
Full-Body Exercise Equipment
By Application
Occupational Rehabilitation & Training
Physical Rehabilitation & Training
By End-Use
Hospitals & Clinics
Rehabilitation Centers
Home-Care Settings
Physiotherapy Centers
Others
By Region
North America
U.S.
Canada
Asia Pacific
China
Japan
India
South Korea
Thailand
Europe
Germany
UK
France
Italy
Spain
Sweden
Denmark
Norway
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
UAE
Saudi Arabia
Kuwait
Get the complete strategic report with expert insights, trends, and competitive benchmarking: https://www.towardshealthcare.com/price/5484
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcareSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Rexel SA (RXEEY) H1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ...
H1 2025 Sales: EUR9.8 billion, up 1.6% on a same-day basis. Q2 2025 Sales: Almost EUR5 billion, up 0.6% on a reported basis. Free Cash Flow Before Interest and Tax: EUR251 million, 42% conversion rate. Adjusted EBITDA Margin H1 2025: 5.8%. Gross Margin: Maintained at 25%. North America Q2 2025 Sales Growth: 8.7% same-day sales growth. Europe Q2 2025 Sales: Down 3% same-day sales. Recurring Net Income H1 2025: EUR308 million. Net Debt: Close to EUR3.1 billion. Indebtedness Ratio: 2.4 times. Digital Sales Q2 2025: 34% of total sales, up nearly 200 basis points year-on-year. Non-Cable Selling Prices Q2 2025: Up 0.9%. Financial Expense H1 2025: EUR107 million. Tax Rate H1 2025: 34.5%. Warning! GuruFocus has detected 3 Warning Signs with GOVX. Release Date: July 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Rexel SA (RXEEY) reported strong sales growth in North America, driven by higher volumes in data centers and broadband infrastructure, contributing significantly to Q2 growth. Digital sales accounted for approximately 34% of total sales in Q2, up nearly 200 basis points year-on-year, supporting top-line growth and future productivity gains. The company achieved a free cash flow conversion rate of 42%, significantly above the five-year H1 average, providing flexibility for strategic investments. Rexel SA (RXEEY) maintained a resilient adjusted EBITDA margin of 5.8% in H1, despite a challenging macroeconomic environment, supported by cost initiatives and a reduction in FTEs. The company completed five acquisitions in 2025, strengthening its footprint in North America and expanding into higher-margin businesses in Canada and Italy. Negative Points The European market remained challenging, with sales declining due to softer demand, a difficult base effect, and lower solar market contributions. Currency effects negatively impacted sales by 2.3% in Q2, primarily due to US dollar depreciation, with an anticipated full-year impact of minus 2.1%. Adjusted EBITDA margin in Europe decreased by 55 basis points, mainly due to under-absorption of fixed costs and competitive pressures. The company faced a EUR124 million fine from the French Competition Authority, impacting free cash flow despite an appeal. Sales in the Asia-Pacific region, particularly in China and Australia, declined due to competitive market conditions and lower volumes in residential and non-residential segments. Q & A Highlights Q: Can you clarify the growth contribution from data centers and broadband in North America? It seems like it's growing at more than 40%. A: Guillaume Texier, CEO: There was a slight acceleration in Q2, but the growth is primarily due to the Talley acquisition, which is growing in strong double digits. Data centers now represent about 5% of our US business, with initiatives in place to increase market penetration, resulting in strong double-digit growth in this segment. Q: How did US tariffs impact pricing in Q2, and what are your expectations for Q3? A: Guillaume Texier, CEO: We saw price increases between 4% and 20% in some categories due to tariffs. However, steel piping experienced double-digit deflation, offsetting some gains. Overall, non-cable prices increased by 2.2% in North America. We expect continued progression in pricing, with potential additional increases depending on tariff developments. Q: Can you elaborate on the early signs of a rebound in Europe? A: Guillaume Texier, CEO: While figures remain negative, we see slight positive trends in residential markets in Switzerland and the UK. Indicators like residential transactions and loan activity are rebounding, suggesting potential market stabilization. However, our H2 assumptions do not anticipate a European rebound. Q: How does increased exposure to data centers and infrastructure in the US impact margins? A: Guillaume Texier, CEO: Margins on these projects are not significantly different from other businesses. Large projects typically have slightly lower gross margins but also lower costs to serve, resulting in equivalent EBITA margins. The volume increase aids fixed cost absorption, making it slightly beneficial overall. Q: Why is the backlog in North America stable despite strong growth in data centers and datacom? A: Guillaume Texier, CEO: The stable backlog is due to improved supply situations, allowing us to service existing orders while receiving new ones. The backlog represents about two to three months of sales, similar to last year, indicating a balanced supply and demand. Q: What actions are being taken to ensure productivity and efficiency in Europe amidst weaker sales? A: Laurent Delabarre, CFO: We are intensifying OpEx discipline and executing restructuring plans, particularly in the UK and Germany. These efforts, along with our Accelerate 2028 program, are expected to yield more savings in H2 compared to H1, with around 20 basis points of savings anticipated for the full year. Q: How do you view the potential for data center sales growth in North America? A: Guillaume Texier, CEO: Data centers currently account for 5% of our North American sales, with potential to grow further. While competitors may have higher exposure, we aim to increase our share through proven value and service delivery, although reaching double-digit percentages organically may be ambitious. Q: Can you provide more details on the current M&A pipeline? A: Guillaume Texier, CEO: The M&A landscape is not very active due to economic uncertainties. We completed five small to mid-sized acquisitions in H1 and continue to pursue opportunities, but 2025 may not be a record year for M&A activity. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
BetMGM raises 2025 forecast on strong iGaming, sports betting growth
(Reuters) -U.S. sports-betting service BetMGM, a joint venture between Entain and MGM Resorts, has raised its full-year 2025 revenue and core earnings forecast after posting a 35% rise in first-half revenue, helped by strong demand in online sports betting and its iGaming division. Growth in player volumes and engagement helped lift iGaming revenue by 28% in the first half, Entain said. Founded in 2018, BetMGM has been expanding its digital footprint to tap into the fast-growing U.S. e-betting market amid stiff competition. BetMGM now expects revenue of at least $2.7 billion and core earnings of at least $150 million in fiscal year 2025, Entain said. It had earlier forecast revenue of at least $2.6 billion, and earnings before interest, taxes, depreciation, and amortization of at least $100 million. Sign in to access your portfolio
Yahoo
23 minutes ago
- Yahoo
TFI International Inc (TFII) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...
Total Revenue Before Fuel Surcharge: $1.8 billion, down from $2 billion a year earlier. Operating Income: $170 million, representing a 9.5% margin. Adjusted Net Income: $112 million, compared to $146 million last year. Adjusted EPS: $1.34, down from $1.71. Net Cash from Operating Activities: $247 million, virtually flat with the prior year. Free Cash Flow: $182 million, up from $151 million in the second quarter of 2024. LTL Revenue Before Fuel Surcharge: $704 million, down 11% year over year. LTL Operating Income: $74 million, compared to $110 million in the prior year. LTL Operating Ratio: 89.5%, compared to 86.2% in the second quarter of 2024. Truckload Revenue Before Fuel Surcharge: $712 million, compared to $738 million a year earlier. Truckload Operating Income: $71 million, versus $81 million in the prior year. Truckload Operating Ratio: 90.1%, relative to 89% in the second quarter of 2024. Logistics Revenue Before Fuel Surcharge: $393 million, down from $442 million in the prior year. Logistics Operating Income: $38 million, compared to $51 million. Logistics Operating Margin: 9.6%, compared to 11.4% in the prior year second quarter. Funded Debt-to-EBITDA Ratio: 2.4 times. Share Repurchases: $85 million worth of shares repurchased during the quarter. Dividends Paid: $39 million, totaling $124 million of capital returned to shareholders. Third Quarter 2025 EPS Outlook: Expected range of $1.10 to $1.25. Net CapEx Expectation for Full Year: Approximately $200 million. Release Date: July 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points TFI International Inc (NYSE:TFII) reported strong free cash flow of $182 million, significantly above the previous year's $151 million. The company maintained a strong balance sheet and further strengthened it through a private placement bond offering. TFI International Inc (NYSE:TFII) achieved a 9.5% operating margin, an improvement from the previous year's 2.5%. The company repurchased $85 million worth of shares and paid out $39 million in dividends, returning a total of $124 million to shareholders. TFI International Inc (NYSE:TFII) implemented technology tools like Optum to improve efficiencies and reduce costs, particularly in linehaul operations. Negative Points Total revenue before fuel surcharge decreased to $1.8 billion from $2 billion a year earlier. Adjusted net income fell to $112 million from $146 million in the previous year, with adjusted EPS dropping from $1.71 to $1.34. The LTL segment saw a decline in revenue and operating income, with an operating ratio increase from 86.2% to 89.5%. Truckload segment revenue and operating income also decreased, with tariff-related uncertainties affecting demand. Logistics segment revenue and operating income declined, with a decrease in operating margin from 11.4% to 9.6%. Q & A Highlights Q: Can you remind us what is the margin ceiling you can achieve with further internal actions before the cycle starts to help you out on the LTL side? A: Alain Bedard, CEO, explained that TFI is very cost-sensitive and has implemented tools like Optum for linehaul and P&D to reduce costs. They have reduced linehaul miles on the rail from over 30% to closer to 20% and aim to further decrease this. Improvements in claims and safety are also targeted, with new hires to enhance safety culture. AI is being explored to reduce labor intensity and costs. Q: Can you give us a little more color on the Q3 guidance, $1.10 to $1.25, and the margin assumptions there? A: David Saperstein, CFO, stated that the guidance is based on historical seasonality, with expected sequential declines in margins across divisions. The company aims to offset some of this with idiosyncratic opportunities. Q: Are you seeing any signs that the macro environment could start to improve in the front half of '26? A: Alain Bedard, CEO, expressed optimism that the new US budget could revive industrial investment, potentially ending the freight recession. However, concrete improvements have not yet been seen, and any recovery might be more evident in late '25 or early '26. Q: Can you talk about the sustainability of the free cash flow? A: Alain Bedard, CEO, emphasized TFI's strong cash generation, even in difficult macro conditions. The company aims to maintain this by focusing on asset-light models, particularly in the US, and expects free cash flow to potentially reach close to $1 billion in a normal environment. Q: Are there any plans for M&A in the LTL sector, given the improvements seen this quarter? A: Alain Bedard, CEO, stated that while M&A for LTL is not currently on the table, the company aims to prove control over TForce Freight first. If successful, they might consider larger transactions in 2026, but for now, they focus on buying back TFI shares. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
